

Yong Lai
262 posts

@YongLaiLab
Synthetic biologist/Assistant Professor @HKUST;Postdoc in RLE in the Lu lab @MIT;PhD in Microbiology @HKUniversity





🚀Building on the success of Dream 7B, we introduce Dream-VL and Dream-VLA, open VL and VLA models that fully unlock discrete diffusion’s advantages in long-horizon planning, bidirectional reasoning, and parallel action generation for multimodal tasks.


Sourdough starter-inspired living materials grown from probiotic consortia with engineered division-of-labor biorxiv.org/content/10.110… #biorxiv_synbio

Know a rising star who studies host-microbe interactions? Nominate an exceptional early-career scientist to author a minireview in #IAIJournal’s 2026 New Voices in Microbiology Collection. Submit your nomination by Aug. 18: asm.social/2vO




🚀Excited to announce Dream 7B (Diffusion reasoning model): the most powerful open diffusion large language model to date.

Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, shares her excitement for the upcoming data presentation from the SENTI-202 trial at the AACR Annual Meeting being held April 25-30, 2025 bit.ly/3QYtOx5 @AACR



Today, we announced positive initial clinical data from the Phase 1 trial of SENTI-202, a potential first-in-class, off-the-shelf #CARNK #celltherapy for R/R hematologic malignancies, including #AML. Learn more on our webcast on Dec. 3 at 7:30am ET: bit.ly/4eUaKtb $SNTI


